AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large increase in short interest in the month of December. As of December 30th, there was short interest totalling 1,440,000 shares, an increase of 52.9% from the December 15th total of 941,700 shares. Approximately 3.8% of the shares of the stock are sold short. Based on an average trading volume of 565,800 shares, the days-to-cover ratio is presently 2.5 days.
AngioDynamics Trading Down 0.4 %
Shares of ANGO stock opened at $13.51 on Friday. AngioDynamics has a fifty-two week low of $11.71 and a fifty-two week high of $24.87. The stock's fifty day moving average price is $13.34 and its two-hundred day moving average price is $17.53. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 2.16. The company has a market cap of $528.70 million, a PE ratio of -16.28 and a beta of 0.66.
Get
AngioDynamics alerts:
Analysts Set New Price Targets
A number of brokerages recently commented on ANGO. Raymond James decreased their price target on AngioDynamics from $25.00 to $22.00 and set a "strong-buy" rating on the stock in a research report on Friday, January 6th. StockNews.com initiated coverage on shares of AngioDynamics in a report on Wednesday, October 12th. They issued a "hold" rating on the stock.
Institutional Trading of AngioDynamics
Several large investors have recently bought and sold shares of the business. BlackRock Inc. lifted its holdings in shares of AngioDynamics by 1.9% in the third quarter. BlackRock Inc. now owns 6,411,415 shares of the medical instruments supplier's stock worth $131,177,000 after acquiring an additional 117,895 shares during the last quarter. Victory Capital Management Inc. grew its stake in shares of AngioDynamics by 3.4% during the second quarter. Victory Capital Management Inc. now owns 2,933,155 shares of the medical instruments supplier's stock worth $56,757,000 after buying an additional 96,263 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of AngioDynamics by 1.7% during the first quarter. Dimensional Fund Advisors LP now owns 2,750,872 shares of the medical instruments supplier's stock worth $59,255,000 after buying an additional 46,173 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of AngioDynamics by 1.5% in the 3rd quarter. Vanguard Group Inc. now owns 2,589,323 shares of the medical instruments supplier's stock valued at $52,977,000 after acquiring an additional 38,898 shares during the last quarter. Finally, Polar Capital Holdings Plc lifted its stake in shares of AngioDynamics by 21.6% in the 1st quarter. Polar Capital Holdings Plc now owns 1,882,375 shares of the medical instruments supplier's stock valued at $40,546,000 after acquiring an additional 334,649 shares during the last quarter. 94.94% of the stock is owned by institutional investors and hedge funds.
AngioDynamics Company Profile
(Get Rating)
AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
See Also
- Get a free copy of the StockNews.com research report on AngioDynamics (ANGO)
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
(获取评级)